FDA Panel Likes Diabetes Drug on Second Try

(MedPage Today) -- An FDA advisory panel has voted 13-1 in favor of approval for dapagliflozin (Forxiga), a type 2 diabetes drug that the agency had turned down last year.
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news